HCSGD entry for PROM1


1. General information

Official gene symbolPROM1
Entrez ID8842
Gene full nameprominin 1
Other gene symbolsAC133 CD133 CORD12 MCDR2 PROML1 RP41 STGD4
Links to Entrez GeneLinks to Entrez Gene

2. Neighbors in the network

color bar
This gene isn't in PPI subnetwork.

3. Gene ontology annotation

GO ID

GO term

Evidence

Category

GO:0001750Photoreceptor outer segmentISScellular_component
GO:0005515Protein bindingIPImolecular_function
GO:0005615Extracellular spaceIEAcellular_component
GO:0005886Plasma membraneIDAcellular_component
GO:0005887Integral component of plasma membraneIEAcellular_component
GO:0005903Brush borderIEAcellular_component
GO:0009986Cell surfaceIDA IEAcellular_component
GO:0010842Retina layer formationISSbiological_process
GO:0016021Integral component of membraneIEAcellular_component
GO:0016324Apical plasma membraneIEAcellular_component
GO:0031528Microvillus membraneIEAcellular_component
GO:0032420StereociliumIEAcellular_component
GO:0042622Photoreceptor outer segment membraneIDAcellular_component
GO:0042805Actinin bindingIDAmolecular_function
GO:0045296Cadherin bindingIPImolecular_function
GO:0045494Photoreceptor cell maintenanceIMPbiological_process
GO:0060042Retina morphogenesis in camera-type eyeIMPbiological_process
GO:0060219Camera-type eye photoreceptor cell differentiationIMP ISSbiological_process
GO:0072112Glomerular visceral epithelial cell differentiationIMPbiological_process
GO:0072139Glomerular parietal epithelial cell differentiationIMPbiological_process
GO:2000768Positive regulation of nephron tubule epithelial cell differentiationIMPbiological_process
Entries Per Page
Displaying Page of

4. Expression levels in datasets

  • Meta-analysis result

p-value upp-value downFDR upFDR down
0.57033939820.43477247450.99999024731.0000000000

  • Individual experiment result
    ( "-" represent NA in the specific microarray platform )

Data sourceUp or downLog fold change
GSE11954Up0.2066960247
GSE13712_SHEARDown-0.0654352177
GSE13712_STATICUp0.1144887486
GSE19018Down-0.3375614649
GSE19899_A1Up0.0260459684
GSE19899_A2Up0.3938854425
PubMed_21979375_A1Up0.0853341890
PubMed_21979375_A2Down-0.0328946089
GSE35957Up0.0923734903
GSE36640Up0.1992471788
GSE54402Up0.1743127819
GSE9593Up0.0949540748
GSE43922Up0.0216926083
GSE24585Down-1.3257288795
GSE37065Down-0.0423809892
GSE28863_A1Up0.0007968684
GSE28863_A2Up0.0975457024
GSE28863_A3Up0.0822605928
GSE28863_A4Up0.0468944639
GSE48662Down-0.0341206581

5. Regulation relationships with compounds/drugs/microRNAs

  • Compounds

Not regulated by compounds

  • Drugs

Not regulated by drugs

  • MicroRNAs

    • mirTarBase

MiRNA_name

mirBase ID

miRTarBase ID

Experiment

Support type

References (Pubmed ID)

hsa-miR-142-3pMIMAT0000434MIRT021645Reporter assayFunctional MTI21394831
Entries Per Page
Displaying Page of
    • mirRecord
No target information from mirRecord

6. Text-mining results about the gene

Gene occurances in abstracts of cellular senescence-associated articles: 7 abstracts the gene occurs.


PubMed ID of the article

Sentenece the gene occurs

26097880We recently developed CAR T cells targeting the prototypic cancer stem cell marker AC133 and showed that these CAR T cells killed AC133+ glioblastoma stem cells (GBM-SCs) in vitro and inhibited the growth of brain tumors initiated from GBM-SCs in xenograft mouse models in vivo
25426558The AC133 epitope of CD133 is a cancer stem cell (CSC) marker for many tumor entities, including the highly malignant glioblastoma multiforme (GBM)
25426558We have developed an AC133-specific chimeric antigen receptor (CAR) and show that AC133-CAR T cells kill AC133+ GBM stem cells (GBM-SCs) both in vitro and in an orthotopic tumor model in vivo
25239491Successful CD133+ mobilizers expressed fewer senescence-associated genes compared with poor mobilizers
25239491However, poor mobilization efficiency combined with high CD133+ senescence suggests futility in this approach
22719071In this study, we used quantitative real-time-PCR to define miRNA expression patterns in various stem/progenitor cell populations in prostate cancer, including CD44+, CD133+, integrin alpha2beta1+, and side population cells
20424141Results of flow cytometry showed that EPCs after 7 days of culture expressed both stem cell markers CD34 and CD133 and endothelial cell markers VEGFR-2 (flk-1) and VE-cadherin
17545049The expressions of CD29, CD44, and CD34 were observed in ASCs by flow cytometry while HLA-DR or CD133 expression was not detected
16698211CD34+/CD133 senescence and in vivo application
Entries Per Page
Displaying Page of